Fundz

QCDx secures $7 million in funding to advance its liquid biopsy technologies, including a new diagnostic instrument and breast cancer assay, led by Sagittarius Advisors LLC.

PRIVATEMay 01, 2025

Amount Raised

$7 Million

Round Type

Funding Round

FarmingtonBiotechnologyHealth CareMedical

Investors

Sagittarius Advisors LLC

Description

QCDx, a diagnostics company focusing on circulating tumor cells, has closed $7 million in financing. This includes $5.3 million in intermediate term debt and $1.7 million in convertible notes converted to equity. The funds will support the launch of new diagnostic tools and a clinical laboratory. QCDx aims to accelerate key milestones with this funding.

Quick answer

QCDx raised $7 Million in a Funding Round round, dated May 1, 2025. Investors: Sagittarius Advisors LLC. QCDx is based in Farmington, Connecticut, United States.

How much did QCDx raise?
QCDx raised $7 Million in a Funding Round round on May 1, 2025.
Who invested in QCDx?
Sagittarius Advisors LLC is named as investors in this round.
What does QCDx do?
QCDx, Inc. is a privately held diagnostics innovator at the forefront of precision oncology.
Where is QCDx based and how big is it?
QCDx is based in Farmington, Connecticut, United States.
Who are the decision-makers at QCDx?
Fundz holds 1 contact at QCDx. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as QCDx that raised within 45 days of this round, from Fundz verified event records.

  • Flomark raised $405K (Seed) on June 12, 2025.
  • Cosm Medical raised an undisclosed amount (Seed) on June 5, 2025.
  • Canid raised $10M (Series A) on June 3, 2025.
  • Femasys raised $1.4M on June 2, 2025.
  • Outcomes4Me raised $21M on May 30, 2025.
  • MAIA Biotechnology raised $695K (Seed) on May 28, 2025.

Who to call at QCDx, and when

A new round usually means QCDx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day QCDx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at QCDx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at QCDx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

QCDx

Location

Farmington, Connecticut, United States

About

QCDx, Inc. is a privately held diagnostics innovator at the forefront of precision oncology. The company develops proprietary liquid biopsy technologies for the enrichment-free detection and proteomic profiling of circulating tumor cells (CTCs), empowering oncologists with real-time insights into tumor heterogeneity, therapeutic targets, and disease progression. Founded by Dr. Triantafyllos Tafas, QCDx delivers its breakthrough capabilities through advanced medical instrumentation and CLIA-certified laboratory services.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment QCDx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for QCDx's next move

See what Strategic adds

QCDx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.